Search clinical trials for: Lenvatinib
Total 458 results
-
Washington University School of MedicineMerck Sharp & Dohme LLCActive, not recruiting
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingRenal Cell CarcinomaPoland, Australia, United States, Canada, France, Hungary, Ireland, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
BeiGeneActive, not recruiting
-
Cancer Institute and Hospital, Chinese Academy...Active, not recruitingHepatocellular Carcinoma | Radiotherapy | LenvatinibChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, HepatocellularUnited States, Australia, Canada, Chile, China, Colombia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingHead and Neck Squamous Cell CarcinomaUnited States, Australia, Brazil, Canada, China, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaSpain, United States, Australia, France, Israel, Italy, South Africa, Switzerland
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CancerPoland, Russian Federation, United States, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
IRCCS San RaffaeleCompleted
-
Eisai Co., Ltd.Merck Sharp & Dohme LLCCompletedHepatocellular CarcinomaUnited States, Spain, France, Italy, Japan, Russian Federation, United Kingdom
-
Shanghai Junshi Bioscience Co., Ltd.TerminatedHepatocellular CarcinomaChina
-
National Cancer Center, KoreaMSD Korea Ltd.Enrolling by invitationAdrenocortical CarcinomaKorea, Republic of
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerChina
-
Eisai Pharmaceuticals India Pvt. LtdCompletedCarcinoma, HepatocellularIndia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingNeuroendocrine Neoplasm | Multiple Endocrine Neoplasia Type 1 | Advanced Carcinoid Tumor | Digestive System Neuroendocrine Neoplasm | Unresectable Carcinoid TumorUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingGlioblastoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Biliary Tract CancersUnited States, Argentina, Australia, Canada, Chile, Colombia, France, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedPoorly Differentiated Thyroid Gland Carcinoma | Recurrent Differentiated Thyroid Gland Carcinoma | Columnar Cell Variant Thyroid Gland Papillary Carcinoma | Follicular Variant Thyroid Gland Papillary Carcinoma | Metastatic Thyroid Gland Follicular Carcinoma | Metastatic Thyroid Gland Papillary... and other conditionsUnited States
-
Eisai Inc.Merck Sharp & Dohme LLCActive, not recruitingEndometrial NeoplasmsFrance, Canada, United States, Spain, United Kingdom, Italy, Taiwan, Korea, Republic of, Colombia, Australia, New Zealand, Brazil, Turkey, Poland, Israel, Argentina, Germany, Ireland, Japan, Mexico, Russian Federation
-
Merck Sharp & Dohme LLCEisai Inc.CompletedAdvanced MelanomaCanada, United States, Australia, Spain, Sweden
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedOsteosarcomaKorea, Republic of, New Zealand, Spain, United States, Sweden, Taiwan, Singapore, Hong Kong, United Kingdom, France, Belgium, Switzerland, Australia, Ireland, Canada, Israel, Italy, Austria, Czechia, Finland, Netherlands
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Chile, China, France, Germany, Israel, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, United Kingdom
-
Humanity & Health Medical Group LimitedBeijing 302 Hospital; Kindai University Faculty of MedicineTerminatedHepatocellular CarcinomaHong Kong
-
Juntendo UniversityMerck Sharp & Dohme LLCActive, not recruitingNon-squamous Non-small-cell Lung Cancer | EGFR Activating MutationJapan
-
CoImmuneTerminatedAdvanced Renal Cell CarcinomaUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, HepatocellularColombia, Israel, Taiwan, United States, Australia, Brazil, Chile, China, Denmark, France, Germany, Hong Kong, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Norway, Portugal, Puerto Rico, Spain, Thailand, Turke... and more
-
First Affiliated Hospital of Wenzhou Medical UniversityQilu Hospital of Shandong University; Eastern Hepatobiliary Surgery Hospital; The First Affiliated Hospital of Zhejiang Chinese Medical UniversityEnrolling by invitationSarcopenia | Liver CancerChina
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingAdvanced Hepatocellular Carcinoma (HCC)Italy, Poland, Singapore, United States, China, Ukraine
-
MedivirActive, not recruitingHepatocellular Carcinoma | Intrahepatic Cholangiocarcinoma | Liver MetastasesKorea, Republic of, Spain, Belgium, United Kingdom
-
Fudan UniversityEnrolling by invitationGastric / Gastroesophageal Junction AdenocarcinomaChina
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedRecurrent and Refractory Solid TumorsUnited States, Canada
-
Institut für Klinische Krebsforschung IKF GmbH...Merck Sharp & Dohme LLC; Medizinische Hochschule Hannover, Germany, Prof. Dr...Active, not recruitingHepatocellular CarcinomaGermany
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingEsophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 | Pathologic Stage... and other conditionsUnited States
-
Shanghai Zhongshan HospitalActive, not recruitingBiliary Tract Cancer | PD-1 Antibody | Lenvatinib | GemoxChina
-
Eisai Co., Ltd.Ono Pharmaceutical Co. LtdCompletedCarcinoma, HepatocellularJapan
-
RenJi HospitalCompletedLenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular CarcinomaHepatocellular Carcinoma | Molecular Targeted TherapyChina
-
Eisai Inc.Merck Sharp & Dohme LLCCompletedTumorsSpain, United States, Norway
-
Eisai Pharmaceuticals India Pvt. LtdActive, not recruiting
-
Eisai LimitedMerck Sharp & Dohme LLCCompletedOsteosarcoma | Tumors | Differentiated Thyroid Cancer (DTC) | Solid Malignant TumorsSpain, Italy, United States, United Kingdom, France, Germany
-
CStone PharmaceuticalsActive, not recruitingHepatocellular CarcinomaSpain, China, United States, Poland, Italy, Taiwan
-
Eisai Inc.Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaKorea, Republic of, Spain, United States, Netherlands, Ireland, Canada, United Kingdom, Poland, Italy, Australia, Russian Federation, Belgium, Israel, France, Greece, Czechia, Switzerland, Austria, Germany, Japan
-
Eisai Inc.CompletedLymphomas | Refractory Solid TumorsUnited States
-
Eisai Inc.Completed
-
Eisai Inc.CompletedThyroid CancerUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Portugal, Romania, Russian Federation, Spain, Sweden, Thailand, United Kingdom
-
Eisai Inc.PharmaBio Development Inc.Terminated
-
Eisai Inc.CompletedEndometrial CancerUnited States, Poland, Ukraine, Bulgaria, Romania, Belgium, Russian Federation, Hungary
-
Zhejiang UniversityCompletedAdvanced Hepatocellular CarcinomaChina
-
Shi MingCompleted